Drug Type Monoclonal antibody |
Synonyms BA 1106, BA-1106, RR-102 + [1] |
Target |
Action inhibitors |
Mechanism IL2RA inhibitors(Interleukin-2 receptor alpha chain inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | China | 21 Nov 2022 | |
Solid tumor | Phase 1 | China | 30 Jan 2022 |